Octagon Capital Advisors

Investor type Private Equity Firm
Founders Ting Jia

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 16
Average round size
info
The average size of a deal this fund participated in
$99M
Portfolio companies 16
Lead investments 1
Exits 1
Key employees Soon
Stages of investment
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Life Science

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Octagon Capital Advisors:
Typical Co-investors
Octagon Capital Advisors is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Octagon Capital Advisors:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
babemax China, Putuo, Shanghai
Beiqing Ruichuang Beijing, Beijing Shi, China
Cooley California, Palo Alto, United States
Cyberlink Corp California, San Jose, United States
Danfu Investment -
Esplanade Ventures Canada, Montréal, Quebec
Essence VC -
GP Ventures Illinois, Illinois City, United States
Huayu Kechuang Beijing, China, Haidian
Hunan Zhongai Social Impact Investment China, Fujian, Hunan
Kodansha Chiyoda, Japan
Millenium Food-Tech -
MPM Bio IV NVS Strategic Fund -
Old Lane LP New York, New York, United States
PKO BP Mazowieckie, Poland, Warszawa
QUBIS Belfast, Northern Ireland, United Kingdom
Ricoh Company Japan, Tokyo
Salamander Invest AS -
Zhiyou Fangcun China, Guangdong, Shenzhen
Zhongjiancai Touzi -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

AnHeart Therapeutics

Biotechnology
$61M14 Dec 2021 Shangcheng District, Zhejiang, China

Allorion Therapeutics

Medical
Pharmaceutical
Therapeutics
$40M24 Nov 2021 Natick, Massachusetts, United States

Edge Medical Robotics

Health Care
$200M06 Nov 2021 Futian District, Guangdong Province, China

Alebund Pharmaceuticals

Biotechnology
Life Science
Pharmaceutical
$54M13 Sep 2021 Shanghai, China

ArriVent Biopharma

Biotechnology
Pharmaceutical
$90M30 Jun 2021 Pennsylvania Furnace, Pennsylvania, United States

NiKang Therapeutics

Biotechnology
Health Care
Medical
$200M26 May 2021 Wilmington, Delaware, United States

Numab

Biopharma
Biotechnology
Health Diagnostics
Life Science
Medical
Therapeutics
$109M19 May 2021 Zurich, Switzerland

Hummingbird Bioscience

Biotechnology
Health Care
Therapeutics
$125M18 May 2021 Singapore, Central Region, Singapore

Affinia Therapeutics

Biotechnology
Health Care
Life Science
Therapeutics
$110M03 May 2021 Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Octagon Capital Advisors?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: